001010199 001__ 1010199
001010199 005__ 20231027114412.0
001010199 0247_ $$2doi$$a10.3390/cancers15143577
001010199 0247_ $$2datacite_doi$$a10.34734/FZJ-2023-03010
001010199 0247_ $$2pmid$$a37509252
001010199 0247_ $$2WOS$$aWOS:001035143600001
001010199 037__ $$aFZJ-2023-03010
001010199 082__ $$a610
001010199 1001_ $$0P:(DE-Juel1)131777$$aLangen, Karl-Josef$$b0$$eCorresponding author
001010199 245__ $$aHybrid PET/MRI in Cerebral Glioma: Current Status and Perspectives
001010199 260__ $$aBasel$$bMDPI$$c2023
001010199 3367_ $$2DRIVER$$aarticle
001010199 3367_ $$2DataCite$$aOutput Types/Journal article
001010199 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1692187485_26395
001010199 3367_ $$2BibTeX$$aARTICLE
001010199 3367_ $$2ORCID$$aJOURNAL_ARTICLE
001010199 3367_ $$00$$2EndNote$$aJournal Article
001010199 500__ $$a„Open access publication funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) – 491111487“
001010199 520__ $$aAdvanced MRI methods and PET using radiolabelled amino acids provide valuable information, in addition to conventional MR imaging, for brain tumour diagnostics. These methods are particularly helpful in challenging situations such as the differentiation of malignant processes from benign lesions, the identification of non-enhancing glioma subregions, the differentiation of tumour progression from treatment-related changes, and the early assessment of responses to anticancer therapy. The debate over which of the methods is preferable in which situation is ongoing, and has been addressed in numerous studies. Currently, most radiology and nuclear medicine departments perform these examinations independently of each other, leading to multiple examinations for the patient. The advent of hybrid PET/MRI allowed a convergence of the methods, but to date simultaneous imaging has reached little relevance in clinical neuro-oncology. This is partly due to the limited availability of hybrid PET/MRI scanners, but is also due to the fact that PET is a second-line examination in brain tumours. PET is only required in equivocal situations, and the spatial co-registration of PET examinations of the brain to previous MRI is possible without disadvantage. A key factor for the benefit of PET/MRI in neuro-oncology is a multimodal approach that provides decisive improvements in the diagnostics of brain tumours compared with a single modality. This review focuses on studies investigating the diagnostic value of combined amino acid PET and 'advanced' MRI in patients with cerebral gliomas. Available studies suggest that the combination of amino acid PET and advanced MRI improves grading and the histomolecular characterisation of newly diagnosed tumours. Few data are available concerning the delineation of tumour extent. A clear additive diagnostic value of amino acid PET and advanced MRI can be achieved regarding the differentiation of tumour recurrence from treatment-related changes. Here, the PET-guided evaluation of advanced MR methods seems to be helpful. In summary, there is growing evidence that a multimodal approach can achieve decisive improvements in the diagnostics of cerebral gliomas, for which hybrid PET/MRI offers optimal conditions.
001010199 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x0
001010199 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
001010199 7001_ $$0P:(DE-Juel1)143792$$aGalldiks, Norbert$$b1
001010199 7001_ $$0P:(DE-Juel1)144215$$aMauler, Jörg$$b2
001010199 7001_ $$0P:(DE-Juel1)173675$$aKocher, Martin$$b3
001010199 7001_ $$0P:(DE-HGF)0$$aFilß, Christian Peter$$b4
001010199 7001_ $$0P:(DE-Juel1)131627$$aStoffels, Gabriele$$b5
001010199 7001_ $$0P:(DE-Juel1)171754$$aRégio Brambilla, Cláudia$$b6
001010199 7001_ $$0P:(DE-Juel1)156479$$aStegmayr, Carina$$b7
001010199 7001_ $$0P:(DE-Juel1)144347$$aWilluweit, Antje$$b8
001010199 7001_ $$0P:(DE-Juel1)156200$$aWorthoff, Wieland Alexander$$b9
001010199 7001_ $$0P:(DE-Juel1)131794$$aShah, Nadim Jon$$b10$$ufzj
001010199 7001_ $$0P:(DE-Juel1)164254$$aLerche, Christoph$$b11
001010199 7001_ $$0P:(DE-Juel1)132318$$aMottaghy, Felix Manuel$$b12$$ufzj
001010199 7001_ $$0P:(DE-Juel1)145110$$aLohmann, Philipp$$b13
001010199 773__ $$0PERI:(DE-600)2527080-1$$a10.3390/cancers15143577$$gVol. 15, no. 14, p. 3577 -$$n14$$p3577 -$$tCancers$$v15$$x2072-6694$$y2023
001010199 8564_ $$uhttps://juser.fz-juelich.de/record/1010199/files/PDF.pdf$$yOpenAccess
001010199 8767_ $$d2023-08-28$$eAPC$$jZahlung erfolgt$$zVoucher?
001010199 909CO $$ooai:juser.fz-juelich.de:1010199$$pdnbdelivery$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire
001010199 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131777$$aForschungszentrum Jülich$$b0$$kFZJ
001010199 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)143792$$aForschungszentrum Jülich$$b1$$kFZJ
001010199 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)144215$$aForschungszentrum Jülich$$b2$$kFZJ
001010199 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)173675$$aForschungszentrum Jülich$$b3$$kFZJ
001010199 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131627$$aForschungszentrum Jülich$$b5$$kFZJ
001010199 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)171754$$aForschungszentrum Jülich$$b6$$kFZJ
001010199 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)156479$$aForschungszentrum Jülich$$b7$$kFZJ
001010199 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)144347$$aForschungszentrum Jülich$$b8$$kFZJ
001010199 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)156200$$aForschungszentrum Jülich$$b9$$kFZJ
001010199 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131794$$aForschungszentrum Jülich$$b10$$kFZJ
001010199 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)164254$$aForschungszentrum Jülich$$b11$$kFZJ
001010199 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132318$$aForschungszentrum Jülich$$b12$$kFZJ
001010199 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145110$$aForschungszentrum Jülich$$b13$$kFZJ
001010199 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
001010199 9141_ $$y2023
001010199 915pc $$0PC:(DE-HGF)0000$$2APC$$aAPC keys set
001010199 915pc $$0PC:(DE-HGF)0001$$2APC$$aLocal Funding
001010199 915pc $$0PC:(DE-HGF)0002$$2APC$$aDFG OA Publikationskosten
001010199 915pc $$0PC:(DE-HGF)0003$$2APC$$aDOAJ Journal
001010199 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2022-11-30
001010199 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2022-11-30
001010199 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2022-11-30
001010199 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2022-11-30
001010199 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
001010199 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2022-11-30
001010199 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
001010199 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-07-31T16:07:06Z
001010199 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-07-31T16:07:06Z
001010199 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2023-07-31T16:07:06Z
001010199 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bCANCERS : 2022$$d2023-10-26
001010199 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-26
001010199 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-26
001010199 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-26
001010199 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-26
001010199 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-26
001010199 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-26
001010199 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-26
001010199 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-26
001010199 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bCANCERS : 2022$$d2023-10-26
001010199 920__ $$lyes
001010199 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
001010199 9201_ $$0I:(DE-Juel1)INM-4-20090406$$kINM-4$$lPhysik der Medizinischen Bildgebung$$x1
001010199 9201_ $$0I:(DE-Juel1)INM-11-20170113$$kINM-11$$lJara-Institut Quantum Information$$x2
001010199 9201_ $$0I:(DE-82)080010_20140620$$kJARA-BRAIN$$lJARA-BRAIN$$x3
001010199 9801_ $$aFullTexts
001010199 980__ $$ajournal
001010199 980__ $$aVDB
001010199 980__ $$aI:(DE-Juel1)INM-3-20090406
001010199 980__ $$aI:(DE-Juel1)INM-4-20090406
001010199 980__ $$aI:(DE-Juel1)INM-11-20170113
001010199 980__ $$aI:(DE-82)080010_20140620
001010199 980__ $$aUNRESTRICTED
001010199 980__ $$aAPC